The introduction of ChatGPT directed the world’s attention to the power of generative artificial intelligence and its applications across industries. Though the potential of AI applied to drug discovery workflows has been known for years, the emphasis and excitement around large, generative models will significantly accelerate the adoption and validation of these tools for biological discovery.
The early results demonstrate that the transition to generative models is an inflection point for the industry. Applications of large language models (LLMs) for target and generative lead…
